Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers
Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · May 2, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring ways to spread important cancer prevention information known as the Latin America and the Caribbean Code Against Cancer. The goal is to see how well different strategies work to share this information in primary healthcare centers in Aparecida de Goiânia. By testing these strategies, researchers aim to improve cancer awareness and prevention efforts in the community.
To participate in this study, you must be an adult (at least 18 years old) and registered at one of the healthcare centers involved. Healthcare professionals who work at these centers for at least three months can also join. Unfortunately, if you have been diagnosed with cancer in the past or are currently receiving cancer treatment, you won’t be eligible. While the study is not yet recruiting participants, those who take part can expect to engage in activities that help improve how cancer prevention information is shared with the public. This trial is an important step toward better health outcomes in the region.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (≥18 years old)
- • Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
- • Healthcare professionals with at least three months of employment at a participating UBS
- • Ability to provide informed consent
- Exclusion Criteria:
- • - Prior diagnosis of any cancer or currently undergoing cancer treatment
About Hospital Israelita Albert Einstein
Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aparecida De Goiania, Go, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported